These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12032964)

  • 1. [Followup of patients with heart valves].
    Vermes E
    Rev Prat; 2002 Apr; 52(7):765-9. PubMed ID: 12032964
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic issues in prosthetic heart valve replacement.
    Verma P; Gambhir DS
    Indian Heart J; 1997; 49(4):373-81. PubMed ID: 9358659
    [No Abstract]   [Full Text] [Related]  

  • 3. [Valvular bioprostheses and anticoagulation].
    Chambaz IC; Nendaz M
    Rev Med Suisse; 2008 Oct; 4(175):2198-202. PubMed ID: 19024573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral anticoagulation in patients with mechanical valve prostheses: evolving protocols with new generation devices.
    Cotrufo M; De Feo M; De Santo LS; Della Corte A; Scardone M; Costanza S
    Ital Heart J; 2005 May; 6(5):401-4. PubMed ID: 15934413
    [No Abstract]   [Full Text] [Related]  

  • 5. [Anticoagulation in patients with cardiac valve prostheses].
    Paparella D; d'Agostino C; Schinosa Lde L
    Recenti Prog Med; 2004 Apr; 95(4):217-25; quiz 237. PubMed ID: 15147070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gains and losses during anticoagulation treatment in patients with mechanical heart valves.
    Filippatos GS; Gavrielatos G; Kremastinos DT
    J Intern Med; 2006 Dec; 260(6):595. PubMed ID: 17116013
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence and prevention of arterial thromboembolic complications in patients with prosthetic heart valves.
    Dale J; Myhre E
    Scand J Haematol Suppl; 1981; 38():121-9. PubMed ID: 6950500
    [No Abstract]   [Full Text] [Related]  

  • 8. Thromboembolic risk in prosthetic valve carriers. Prevention trial.
    Farah E; Cadhilac M; Boubaker A; Starkman C; Acar J
    Scand J Haematol Suppl; 1981; 38():97-119. PubMed ID: 6950503
    [No Abstract]   [Full Text] [Related]  

  • 9. [Anticoagulant treatment during pregnancy in patients with prosthetic valves].
    Salazar E
    Arch Inst Cardiol Mex; 1988; 58(5):387-8. PubMed ID: 3219000
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anticoagulant and platelet-inhibition therapy of patients with artificial heart valves].
    Boda Z; Voith L; Udvardy M; Hársfalvi J; Pfliegler G; Tornai I
    Orv Hetil; 1987 Feb; 128(5):239-42. PubMed ID: 3547248
    [No Abstract]   [Full Text] [Related]  

  • 11. Improving the quality of anticoagulant therapy in patients with mechanical heart valves: what are we waiting for?
    Herijgers P; Verhamme P
    Eur Heart J; 2007 Oct; 28(20):2424-6. PubMed ID: 17890728
    [No Abstract]   [Full Text] [Related]  

  • 12. Mitral valve replacement and thromboembolic risk.
    Benussi S; Verzini A; Alfieri O
    J Heart Valve Dis; 2004 May; 13 Suppl 1():S81-3. PubMed ID: 15225011
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heart valve prosthesis and anticoagulant treatment. Apropos of 240 patients, including 57 without treatment].
    Ismaïl MB; Houissa R; Cabane J; Richard C; Enriquez-Sarano L; Kafsi N
    Coeur Med Interne; 1978; 17(1):19-27. PubMed ID: 639485
    [No Abstract]   [Full Text] [Related]  

  • 14. Optimization of oral anticoagulation for patients with mechanical heart valve prostheses.
    Piper C; Schulte HD; Horstkotte D
    J Heart Valve Dis; 1995 Mar; 4(2):127-37. PubMed ID: 8556172
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Arterial thromboembolism and prosthetic heart valves. Effects of acetylsalicylic acid.
    Dale J; Myhre E; Storstein O; Stormorken H
    Thromb Diath Haemorrh; 1975 Nov; 34(2):587-8. PubMed ID: 1105879
    [No Abstract]   [Full Text] [Related]  

  • 16. Managing mechanical valves with reduced anticoagulation.
    Slaughter MS; Jweied E
    Expert Rev Cardiovasc Ther; 2007 Nov; 5(6):1073-85. PubMed ID: 18035923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.
    Stein PD; Alpert JS; Copeland J; Dalen JE; Goldman S; Turpie AG
    Chest; 1992 Oct; 102(4 Suppl):445S-455S. PubMed ID: 1395828
    [No Abstract]   [Full Text] [Related]  

  • 18. [Haemorrhagic and thrombo-embolic complications in patients with prosthetic valves--the under-appreciated problem with no safe solutions].
    Trzeciak P; Poloński L; Zembala M
    Kardiol Pol; 2006 Sep; 64(9):1038-42. PubMed ID: 17054041
    [No Abstract]   [Full Text] [Related]  

  • 19. Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.
    Stassano P; Di Tommaso L; Monaco M; Iorio F; Pepino P; Spampinato N; Vosa C
    J Am Coll Cardiol; 2009 Nov; 54(20):1862-8. PubMed ID: 19892237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of mechanical valve performance in a poorly anticoagulated community.
    Williams MA; Crause L; Van Riet S
    J Card Surg; 2004; 19(5):410-4. PubMed ID: 15383051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.